BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El Sahili A, Lescar J. Dengue Virus Non-Structural Protein 5. Viruses 2017;9:E91. [PMID: 28441781 DOI: 10.3390/v9040091] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Kaushik S, Kaushik S, Kumar R, Dar L, Yadav JP. In-vitro and in silico activity of Cyamopsis tetragonoloba (Gaur) L. supercritical extract against the dengue-2 virus. Virusdisease 2020;:1-9. [PMID: 32904730 DOI: 10.1007/s13337-020-00624-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
2 Torres MC, Martins Karl AL, Müller Pereira da Silva M, Dardenne LE, Bispo de Filippis AM. In Silico Analysis of Dengue Virus Serotype 2 Mutations Detected at the Intrahost Level in Patients with Different Clinical Outcomes. Microbiol Spectr 2021;9:e0025621. [PMID: 34468189 DOI: 10.1128/Spectrum.00256-21] [Reference Citation Analysis]
3 Mirza MU, Vanmeert M, Froeyen M, Ali A, Rafique S, Idrees M. In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors. Sci Rep 2019;9:6809. [PMID: 31048746 DOI: 10.1038/s41598-019-43129-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
4 Nasar S, Rashid N, Iftikhar S. Dengue proteins with their role in pathogenesis, and strategies for developing an effective anti-dengue treatment: A review. J Med Virol 2020;92:941-55. [PMID: 31784997 DOI: 10.1002/jmv.25646] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Gallardo-Flores CE, Colpitts CC. Cyclophilins and Their Roles in Hepatitis C Virus and Flavivirus Infections: Perspectives for Novel Antiviral Approaches. Pathogens 2021;10:902. [PMID: 34358052 DOI: 10.3390/pathogens10070902] [Reference Citation Analysis]
6 Gopala Reddy SB, Chin WX, Shivananju NS. Dengue virus NS2 and NS4: Minor proteins, mammoth roles. Biochem Pharmacol 2018;154:54-63. [PMID: 29674002 DOI: 10.1016/j.bcp.2018.04.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
7 Alamri MA, Mirza MU, Adeel MM, Ashfaq UA, Tahir ul Qamar M, Shahid F, Ahmad S, Alatawi EA, Albalawi GM, Allemailem KS, Almatroudi A. Structural Elucidation of Rift Valley Fever Virus L Protein towards the Discovery of Its Potential Inhibitors. Pharmaceuticals 2022;15:659. [DOI: 10.3390/ph15060659] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cheng D, Huang S, Chin W, Hung S, Tsai H, Chu JJH, Chao C, Wang J. Impact of Intrahost NS5 Nucleotide Variations on Dengue Virus Replication. Front Microbiol 2022;13:894200. [DOI: 10.3389/fmicb.2022.894200] [Reference Citation Analysis]
9 Vora J, Patel S, Athar M, Sinha S, Chhabria MT, Jha PC, Shrivastava N. Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds. J Biomol Struct Dyn 2020;38:1726-40. [PMID: 31057055 DOI: 10.1080/07391102.2019.1615002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Dechtawewat T, Roytrakul S, Yingchutrakul Y, Charoenlappanit S, Siridechadilok B, Limjindaporn T, Mangkang A, Prommool T, Puttikhunt C, Songprakhon P, Kongmanas K, Kaewjew N, Avirutnan P, Yenchitsomanus PT, Malasit P, Noisakran S. Potential Phosphorylation of Viral Nonstructural Protein 1 in Dengue Virus Infection. Viruses 2021;13:1393. [PMID: 34372598 DOI: 10.3390/v13071393] [Reference Citation Analysis]
11 Roy SK, Bhattacharjee S. Dengue virus: epidemiology, biology, and disease aetiology. Can J Microbiol 2021;:1-16. [PMID: 34171205 DOI: 10.1139/cjm-2020-0572] [Reference Citation Analysis]
12 Venkataraman S, Prasad BVLS, Selvarajan R. RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution. Viruses 2018;10:E76. [PMID: 29439438 DOI: 10.3390/v10020076] [Cited by in Crossref: 108] [Cited by in F6Publishing: 88] [Article Influence: 27.0] [Reference Citation Analysis]
13 Wang S, Chan KWK, Naripogu KB, Swarbrick CMD, Aaskov J, Vasudevan SG. Subgenomic RNA from Dengue Virus Type 2 Suppresses Replication of Dengue Virus Genomes and Interacts with Virus-Encoded NS3 and NS5 Proteins. ACS Infect Dis 2020;6:436-46. [PMID: 31922712 DOI: 10.1021/acsinfecdis.9b00384] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
14 Cross ST, Michalski D, Miller MR, Wilusz J. RNA regulatory processes in RNA virus biology. Wiley Interdiscip Rev RNA 2019;10:e1536. [PMID: 31034160 DOI: 10.1002/wrna.1536] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
15 Fischer TR, Meidner L, Schwickert M, Weber M, Zimmermann RA, Kersten C, Schirmeister T, Helm M. Chemical biology and medicinal chemistry of RNA methyltransferases. Nucleic Acids Res 2022:gkac224. [PMID: 35412633 DOI: 10.1093/nar/gkac224] [Reference Citation Analysis]
16 Yang SNY, Atkinson SC, Fraser JE, Wang C, Maher B, Roman N, Forwood JK, Wagstaff KM, Borg NA, Jans DA. Novel Flavivirus Antiviral That Targets the Host Nuclear Transport Importin α/β1 Heterodimer. Cells 2019;8:E281. [PMID: 30909636 DOI: 10.3390/cells8030281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
17 Buendia-Atencio C, Pieffet GP, Montoya-Vargas S, Martínez Bernal JA, Rangel HR, Muñoz AL, Losada-Barragán M, Segura NA, Torres OA, Bello F, Suárez AI, Rodríguez AK. Inverse Molecular Docking Study of NS3-Helicase and NS5-RNA Polymerase of Zika Virus as Possible Therapeutic Targets of Ligands Derived from Marcetia taxifolia and Its Implications to Dengue Virus. ACS Omega 2021;6:6134-43. [PMID: 33718704 DOI: 10.1021/acsomega.0c04719] [Reference Citation Analysis]
18 Shanmugam A, Ramakrishnan C, Velmurugan D, Gromiha MM. Identification of Potential Inhibitors for Targets Involved in Dengue Fever. Curr Top Med Chem 2020;20:1742-60. [PMID: 32552652 DOI: 10.2174/1568026620666200618123026] [Reference Citation Analysis]
19 García-ariza LL, Rocha-roa C, Padilla-sanabria L, Castaño-osorio JC. Virtual Screening of Drug-Like Compounds as Potential Inhibitors of the Dengue Virus NS5 Protein. Front Chem 2022;10:637266. [DOI: 10.3389/fchem.2022.637266] [Reference Citation Analysis]
20 Verma M, Bhatnagar S, Kumari K, Mittal N, Sukhralia S, Gopirajan At S, Dhanaraj PS, Lal R. Highly conserved epitopes of DENV structural and non-structural proteins: Candidates for universal vaccine targets. Gene 2019;695:18-25. [PMID: 30738967 DOI: 10.1016/j.gene.2019.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
21 Caraballo GI, Rosales R, Viettri M, Castillo JM, Cruz R, Ding S, Greenberg HB, Ludert JE. The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells. J Virol 2022;:e0070422. [PMID: 35652656 DOI: 10.1128/jvi.00704-22] [Reference Citation Analysis]
22 Gharbi-Ayachi A, Santhanakrishnan S, Wong YH, Chan KWK, Tan ST, Bates RW, Vasudevan SG, El Sahili A, Lescar J. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase. J Virol 2020;94:e00794-20. [PMID: 32796069 DOI: 10.1128/JVI.00794-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Panwar A, Wangchuk J, Kar M, Lodha R, Medigeshi GR. Dengue virus replication enhances labile zinc pools by modulation of ZIP8. Cell Microbiol 2021;23:e13395. [PMID: 34619004 DOI: 10.1111/cmi.13395] [Reference Citation Analysis]
24 Maddipati VC, Mittal L, Mantipally M, Asthana S, Bhattacharyya S, Gundla R. A Review on the Progress and Prospects of Dengue Drug Discovery Targeting NS5 RNA- Dependent RNA Polymerase. Curr Pharm Des 2020;26:4386-409. [PMID: 32445444 DOI: 10.2174/1381612826666200523174753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Bhatnagar P, Sreekanth GP, Murali-Krishna K, Chandele A, Sitaraman R. Dengue Virus Non-Structural Protein 5 as a Versatile, Multi-Functional Effector in Host-Pathogen Interactions. Front Cell Infect Microbiol 2021;11:574067. [PMID: 33816326 DOI: 10.3389/fcimb.2021.574067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Hengphasatporn K, Plaimas K, Suratanee A, Wongsriphisant P, Yang JM, Shigeta Y, Chavasiri W, Boonyasuppayakorn S, Rungrotmongkol T. Target Identification Using Homopharma and Network-Based Methods for Predicting Compounds Against Dengue Virus-Infected Cells. Molecules 2020;25:E1883. [PMID: 32325755 DOI: 10.3390/molecules25081883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Chen S, Yang C, Zhang W, Mahalingam S, Wang M, Cheng A. Flaviviridae virus nonstructural proteins 5 and 5A mediate viral immune evasion and are promising targets in drug development. Pharmacol Ther 2018;190:1-14. [PMID: 29742479 DOI: 10.1016/j.pharmthera.2018.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
28 Dighe SN, Ekwudu O, Dua K, Chellappan DK, Katavic PL, Collet TA. Recent update on anti-dengue drug discovery. Eur J Med Chem 2019;176:431-55. [PMID: 31128447 DOI: 10.1016/j.ejmech.2019.05.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
29 Bhattarai BR, Adhikari B, Basnet S, Shrestha A, Marahatha R, Aryal B, Rayamajhee B, Poudel P, Parajuli N, Gutiérrez-grijalva E. In Silico Elucidation of Potent Inhibitors from Natural Products for Nonstructural Proteins of Dengue Virus. Journal of Chemistry 2022;2022:1-12. [DOI: 10.1155/2022/5398239] [Reference Citation Analysis]
30 Nncube NB, Ramharack P, Soliman MES. Using bioinformatics tools for the discovery of Dengue RNA-dependent RNA polymerase inhibitors. PeerJ 2018;6:e5068. [PMID: 30280009 DOI: 10.7717/peerj.5068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
31 Cheng CX, Alvin Tan MJ, Chan KWK, Watanabe S, Wang S, Choy MM, Manuel M, Victorio CBL, Ong J, Reolo M, Chacko AM, Vasudevan SG. In Vitro and In Vivo Stability of P884T, a Mutation that Relocalizes Dengue Virus 2 Non-structural Protein 5. ACS Infect Dis 2021;7:3277-91. [PMID: 34735113 DOI: 10.1021/acsinfecdis.1c00441] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Rodriguez AK, Muñoz AL, Segura NA, Rangel HR, Bello F. Molecular characteristics and replication mechanism of dengue, zika and chikungunya arboviruses, and their treatments with natural extracts from plants: An updated review. EXCLI J 2019;18:988-1006. [PMID: 31762724 DOI: 10.17179/excli2019-1825] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
33 Arora R, Liew CW, Soh TS, Otoo DA, Seh CC, Yue K, Nilar S, Wang G, Yokokawa F, Noble CG, Chen YL, Shi PY, Lescar J, Smith TM, Benson TE, Lim SP. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies. J Virol 2020;94:e01130-20. [PMID: 32907977 DOI: 10.1128/JVI.01130-20] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
34 Kar M, Khan NA, Panwar A, Bais SS, Basak S, Goel R, Sopory S, Medigeshi GR. Zinc Chelation Specifically Inhibits Early Stages of Dengue Virus Replication by Activation of NF-κB and Induction of Antiviral Response in Epithelial Cells. Front Immunol 2019;10:2347. [PMID: 31632411 DOI: 10.3389/fimmu.2019.02347] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
35 Kaushik S, Dar L, Kaushik S, Yadav JP. Anti-dengue activity of super critical extract and isolated oleanolic acid of Leucas cephalotes using in vitro and in silico approach. BMC Complement Med Ther 2021;21:227. [PMID: 34496833 DOI: 10.1186/s12906-021-03402-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Bere AW, Mulati O, Kimotho J, Ng'ong'a F. Carica papaya Leaf Extract Silver Synthesized Nanoparticles Inhibit Dengue Type 2 Viral Replication In Vitro. Pharmaceuticals (Basel) 2021;14:718. [PMID: 34451815 DOI: 10.3390/ph14080718] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 van den Elsen K, Quek JP, Luo D. Molecular Insights into the Flavivirus Replication Complex. Viruses 2021;13:956. [PMID: 34064113 DOI: 10.3390/v13060956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
38 Alves AMB, Costa SM, Pinto PBA. Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge? Front Med Technol 2021;3:640964. [PMID: 35047911 DOI: 10.3389/fmedt.2021.640964] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Leonel CA, Lima WG, dos Santos M, Ferraz AC, Taranto AG, de Magalhães JC, dos Santos LL, Ferreira JMS. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds. Arch Virol 2018;163:575-86. [DOI: 10.1007/s00705-017-3641-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
40 De Falco L, Silva NM, Santos NC, Huber RG, Martins IC. The Pseudo-Circular Genomes of Flaviviruses: Structures, Mechanisms, and Functions of Circularization. Cells 2021;10:642. [PMID: 33805761 DOI: 10.3390/cells10030642] [Reference Citation Analysis]
41 El Sahili A, Soh TS, Schiltz J, Gharbi-Ayachi A, Seh CC, Shi PY, Lim SP, Lescar J. NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues. J Virol 2019;94:e01294-19. [PMID: 31597763 DOI: 10.1128/JVI.01294-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
42 Tripathi NK, Shrivastava A. Recent Developments in Recombinant Protein-Based Dengue Vaccines. Front Immunol 2018;9:1919. [PMID: 30190720 DOI: 10.3389/fimmu.2018.01919] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
43 Ahmad Z, Poh CL. The Conserved Molecular Determinants of Virulence in Dengue Virus. Int J Med Sci 2019;16:355-65. [PMID: 30911269 DOI: 10.7150/ijms.29938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
44 Kaptein SJF, Vincetti P, Crespan E, Rivera JIA, Costantino G, Maga G, Neyts J, Radi M. Identification of Broad-Spectrum Dengue/Zika Virus Replication Inhibitors by Functionalization of Quinoline and 2,6-Diaminopurine Scaffolds. ChemMedChem 2018;13:1371-6. [DOI: 10.1002/cmdc.201800178] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
45 Badolo A, Burt F, Daniel S, Fearns R, Gudo ES, Kielian M, Lescar J, Shi Y, von Brunn A, Weiss SR, Hilgenfeld R. Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018. Antiviral Res 2019;162:142-50. [PMID: 30597184 DOI: 10.1016/j.antiviral.2018.12.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Alkaff AH, Saragih M, Fardiansyah MA, Tambunan USF. Role of Immunoinformatics in Accelerating Epitope-Based Vaccine Development against Dengue Virus. TOBIOCJ 2020;14:9-18. [DOI: 10.2174/1874091x02014010009] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Hartini Y, Saputra B, Wahono B, Auw Z, Indayani F, Adelya L, Namba G, Hariono M. Biflavonoid as potential 3-chymotrypsin-like protease (3CLpro) inhibitor of SARS-Coronavirus. Results Chem 2021;3:100087. [PMID: 33520632 DOI: 10.1016/j.rechem.2020.100087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
48 Natali EN, Babrak LM, Miho E. Prospective Artificial Intelligence to Dissect the Dengue Immune Response and Discover Therapeutics. Front Immunol 2021;12:574411. [PMID: 34211454 DOI: 10.3389/fimmu.2021.574411] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Saw WG, Chan KW, Vasudevan SG, Grüber G. Zika virus nonstructural protein 5 residue R681 is critical for dimer formation and enzymatic activity. FEBS Lett 2019;593:1272-91. [PMID: 31090058 DOI: 10.1002/1873-3468.13437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Anasir MI, Ramanathan B, Poh CL. Structure-Based Design of Antivirals against Envelope Glycoprotein of Dengue Virus. Viruses 2020;12:E367. [PMID: 32225021 DOI: 10.3390/v12040367] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
51 Abdullah AA, Lee YK, Chin SP, Lim SK, Lee VS, Othman R, Othman S, Rahman NA, Yusof R, Heh CH. Discovery of Dengue Virus Inhibitors. Curr Med Chem 2020;27:4945-5036. [PMID: 30514185 DOI: 10.2174/0929867326666181204155336] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Lim Chong W, Vao-soongnern V, Nimmanpipug P, Tayapiwatana C, Lin J, Lin Y, Yee Chee H, Md Zain S, Abd Rahman N, Sanghiran Lee V. Molecular dynamics simulations and Gaussian network model for designing antibody mimicking protein towards dengue envelope protein. Journal of Molecular Liquids 2022;346:118086. [DOI: 10.1016/j.molliq.2021.118086] [Reference Citation Analysis]
53 Villegas PM, Ortega E, Villa-Tanaca L, Barrón BL, Torres-Flores J. Inhibition of dengue virus infection by small interfering RNAs that target highly conserved sequences in the NS4B or NS5 coding regions. Arch Virol 2018;163:1331-5. [PMID: 29392497 DOI: 10.1007/s00705-018-3757-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
54 Hosseini S, Muñoz-soto RB, Oliva-ramírez J, Vázquez-villegas P, Aghamohammadi N, Rodriguez-garcia A, Martinez-chapa SO. Latest Updates in Dengue Fever Therapeutics: Natural, Marine and Synthetic Drugs. CMC 2020;27:719-44. [DOI: 10.2174/0929867325666180629124709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Panya A, Songprakhon P, Panwong S, Jantakee K, Kaewkod T, Tragoolpua Y, Sawasdee N, Lee VS, Nimmanpipug P, Yenchitsomanus PT. Cordycepin Inhibits Virus Replication in Dengue Virus-Infected Vero Cells. Molecules 2021;26:3118. [PMID: 34071102 DOI: 10.3390/molecules26113118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]